your market intelligence analyst
Search Results
533 results
Your search is now limited to «Cancer Drugs» expert search.
Xconomy 10/16/2019 12:15
Eli Lilly (NYSE: LLY) said Wednesday that patients treated with its drug candidate pegilodecakin, plus chemotherapy, did not live longer than patients treated with chemotherapy alone, falling short of the main goal of a Phase 3 study.
More from Xconomy:
BioPharma Dive 10/16/2019 11:21
The drug's failure to show a survival benefit in pancreatic cancer narrows those prospects, and puts greater importance on two Phase 2 lung cancer studies expected to read out results in early 2020.
More from BioPharma Dive:
Medical Xpress - Cancer News 10/16/2019 10:06
The important trial could lead to a much-needed new treatment for patients with alveolar soft part sarcoma (ASPS), which tends to affect younger adults and does not respond well to existing treatments.
More from Medical Xpress - Cancer News:
ENDPOINTS 10/16/2019 07:54
Recently we’ve seen a number of new R&D chiefs take their places at the Big 15, either setting the stage for a more focused R&D strategy — often playing more heavily in oncology.
More from ENDPOINTS: 10/16/2019 07:28
As APOBEC3B is not an essential part of the body's immune response, its inhibition could support existing cancer therapies by stopping cancer cells developing resistance to the treatments.
More from
Technology Org 10/16/2019 02:50
A Yale-developed drug shows promise as immune therapy for cancer.
More from Technology Org: 10/15/2019 12:00
Condition : Colorectal Cancer Interventions : Drug: Regorafenib (BAY73-4506, Stivarga); Biological: Nivolumab (Opdivo) Sponsors : Bayer; Bristol-Myers Squibb Not yet recruiting.
More from
Vincristine is used to manage the most common childhood cancer, acute lymphoblastic leukemia and to treat Wilms tumor, a rare kidney cancer.
More from Healthcare Policy:
GlobeNewswire 10/15/2019 08:00
Chris brings more than two decades of oncology drug development proficiency, including the clinical development and global registrations of several marketed cancer medicines,” said Scott Tariff, Ziopharm’s Chairman.
More from GlobeNewswire:
ETHealthWorld (India) 10/15/2019 07:35
The company is facing more than 13,000 lawsuits tied to anti-psychotic drug Risperdal as well as a range of lawsuits involving its baby powder, opioids, medical devices and other products.
More from ETHealthWorld (India):
NASDAQ 10/15/2019 07:15
The company is facing more than 13,000 lawsuits tied to antipsychotic drug Risperdal as well as a range of lawsuits involving its baby powder, opioids, medical devices and other products.
More from NASDAQ:
More importantly, the global Platinum based Cancer Drug competition, industry environment, eminent players, and market segmentation are greatly emphasized in the market with vital insights.
More from Middle East North Africa Financial Network (MENAFN):
Folic acid (FA)-functionalized nanoformulations may enhance the sustained release of an anticancer drug (curcumin) by tumor-specific targeting to improve therapeutic benefit.
More from International Journal of COPD:
FDLI SmartBrief 10/14/2019 12:32
The decision allows use of the drug through the CDF but is not recommended for routine use among patients with ovarian cancer.
More from FDLI SmartBrief:
STAT 10/14/2019 04:35
Outrage about the rising prices of prescription drugs has put cancer drugs in the spotlight.
More from STAT:
FiercePharmaManufacturing 10/13/2019 19:56
Novartis, following fellow cancer drug makers, turns to TV advertising with new Piqray campaign.
More from FiercePharmaManufacturing:
PubMed News (NIH) 10/12/2019
Recent genomic profiling of primary BTCs identified a number of potentially actionable drug targets, however accurate model systems to evaluate these targets are currently lacking.
More from PubMed News (NIH):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications